TITLE

Prescription drug expenditures rising -- too fast?

PUB. DATE
May 2005
SOURCE
CMAJ: Canadian Medical Association Journal;5/10/2005, Vol. 172 Issue 10, p1261
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
Comments on the rising cost of prescription drugs in Canada. Rank of Canada among developed countries with the highest annual rate of prescription drug cost; Total cost of prescription drug cost in Canada in 2004; Discussion on the reasons for the rising cost of prescription drug in the country.
ACCESSION #
16893630

 

Related Articles

  • Policymakers eye increased prescription drug spending, PBM promotional activities. Wechsler, Jill // Formulary;Nov98, Vol. 33 Issue 11, p1147 

    Reports that United States policy makers are eyeing increased prescription drug spending and pharmacy benefit management promotional activities in light of the rising health care spending. Prediction for a major surge in health care spending; Congress' concern that developments are affecting...

  • What is the cost of administration really worth? Eder, Rob // Drug Store News;10/6/2003, Vol. 25 Issue 13, p14 

    Comments on the administrative costs of health care in the United States. Ways in which the rebate situation has made it impossible for a doctor to tell what drug is cheapest; Argument that the secretive rebate system of pharmacy benefits managers (PBM) moves more expensive drugs to the top of...

  • Group says drug prices not only premium increase factor. Reed, Vita // Las Vegas Business Press;04/24/2000, Vol. 17 Issue 16, p17 

    Highlights the results of a survey commissioned by the Pharmaceutical Research and Manufacturers Association of America regarding drug expenditures' role in premium increases. Response to claims made by insurance firms, consumer groups and others that prescription drug spending is a primary...

  • The Great Pharmacy Rip-off. Ragg, Mark // Bulletin with Newsweek;12/08/98, Vol. 117 Issue 6152, p26 

    Presents information on the deal between the Australian government under Hawke and the Pharmacy Guild over the price charged to the public for prescription drugs. The government and the pharmacists agreeing that the public should pay more; Secrecy about the agreement; Details on the various...

  • Drug costs continue to rise. Alfaro, Aura N. // Caribbean Business;7/1/1999, Vol. 27 Issue 25, p26 

    Reports that healthcare costs in Puerto Rico continue to rise. Biggest increase in prescription drug prices followed by hospitalization costs; Increase in drug costs for health insurers because many pharmacy chains are not honoring discounts; Pharmaceutical companies' move to advertise specific...

  • Pfizer takes leading role in drug-price debate. Arnold, Matthew // Medical Marketing & Media;Aug2004, Vol. 39 Issue 8, p32 

    Reports on the launch of Helpful Answer, the brand for beefed-up roster of patient assistance programs by Pfizer Inc. in the U.S. Effort of the pharmaceutical industry to alleviate the high cost of drugs to uninsured Americas; Leadership role of Pfizer Inc. in drug-price debate; Expansion of the...

  • Pharmaceutical assistance programs walk a high wire while looking for ways to save money.  // State Health Watch;Aug2004, Vol. 11 Issue 8, p1 

    Reports on an increase in state pharmaceutical assistance program drug expenditures in the U.S., according to a report funded by The Commonwealth Fund in 2004. Increase in prescription claim costs between 1999 and 2000; Options available to states for controlling program utilization and costs;...

  • Spending on drugs approaching $15 billion a year: CIHI. Sibbald, Barbara // CMAJ: Canadian Medical Association Journal;5/01/2001, Vol. 164 Issue 9, p1333 

    Discusses a report from the Canadian Institute for Health Information which indicates that spending on drugs in 2000 increased. Argument of generic drug companies that rising prices and increased patent protection are making drugs less accessible; Claim of brand name drug manufacturers that...

  • Drug prices stable but total spending rises by 15%. Buske, Lynda // CMAJ: Canadian Medical Association Journal;8/20/2002, Vol. 167 Issue 4, p390 

    Gives the results of the annual report of the Patented Medicine Prices Review Board. Value of the total sales of drug manufacturers; Growth in drug expenditures and fees; Prices of patented drugs sold in Canada.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics